Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lapam Capital
Beijing, Beijing, Chinapreqin.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Invests primarily in early to mid-stage fast-growing life science and healthcare companies developing innovative pharmaceuticals and medical devices. As an investment firm, Lapam Capital does not conduct clinical trials or report results directly. However, many of its portfolio companies are advancing assets into IND-enabling studies or early-phase clinical trials, for example, LTZ Therapeutics is supporting its IND process and initiating Phase 1 clinical study. The firm has invested in over 120 projects, with more than 80% being innovative drug therapeutics projects.
- Therapeutic areas
- OncologyRare DiseasesImmunologyOtherNeurology
- Modalities
- Small moleculeMonoclonal antibodyMolecular glue therapyBiologicGene therapy
- Industry
- Investors
02
Partnerships
Hillhouse Capital ManagementLilly Asia VenturesGL VenturesProxima Ventures Ltd.
Beyond the preview
Go deeper on Lapam Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lapam Capital.